logo
Select company
Select metric
$ 0Interest Expense
VS
Market
69
Sector
59
Industry
47
History
53
$ 1.81Close
$ 0.39 - $ 1.81 52-Week Range
Ticker Information

Ticker

LCTX

Company Name

LINEAGE CELL THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

LINEAGE CELL THERAPEUTICS INC - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LCTX - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 435K
6/30/2023$ 51K
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. stands at $ 1.69M.
  • Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average Int. Exp. has been $ 84.4K.
  • The median Int. Exp. for LINEAGE CELL THERAPEUTICS INC during this period was $ 0
  • LINEAGE CELL THERAPEUTICS INC reached its highest Int. Exp. over the past 5 years at $ 1.69M.
  • The lowest Int. Exp. recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe $ -436K

LINEAGE CELL THERAPEUTICS INC's Int. Exp. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. Benchmarks
CompanyInt. Exp.
TVRD : TVARDI THERAPEUTICS INC $ 7.45MCRBU : CARIBOU BIOSCIENCES INC $ 0SRZN : SURROZEN INC $ 0PRTA : PROTHENA CORP PUBLIC LTD CO $ 0FATE : FATE THERAPEUTICS INC $ 0KRRO : KORRO BIO INC $ 0CAPR : CAPRICOR THERAPEUTICS INC $ 0TNXP : TONIX PHARMACEUTICALS HOLDING CORP $ 0OCGN : OCUGEN INC $ 1.97MCRVO : CERVOMED INC $ 0

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

LCTX - Interest Expense, Last 5 years

$ -436K

Minimum

Sep 30, 2022

$ 1.69M

Maximum

Sep 30, 2020

$ 84.4K

Average

$ 0

Median

Int. Exp. Benchmark Analysis

The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.75M with a standard deviation of $ 5.5M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.72K
min$ -15.41M
max$ 22.87M
average$ 2.75M
median$ 17.64K
std$ 5.5M